Prodia Diagnostic Line Tbk vs Rans Entertainmen Indonesia Tbk — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume), while Rans Entertainmen Indonesia Tbk trades at Rp202 (market cap 2.57T, 37.7M 24h volume). The key difference: Rans Entertainmen Indonesia Tbk is far larger — about 5.5× Prodia Diagnostic Line Tbk's market cap, and Rans Entertainmen Indonesia Tbk is more actively traded (37.7M versus 28.43M). Which is the better fit depends on your goals.
| PRDL | RANS | |
|---|---|---|
Market Cap | 470.58B | 2.57T |
Volume | 28.43M | 37.7M |
Lot | 284.34K | 377K |
Turnover | 7.8B | 7.61B |
Average Price | 274.19 | 201.85 |
Value | 7.8B | 7.61B |
Indicative Equilibrium Price | 270 | 202 |
Indicative Equilibrium Volume | 2.1K | 5.98K |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT. Rans Entertainmen Indonesia Tbk. (the Company) was established with Deed No. 04 on October 18, 2016, which was made before Raden Mas Dendy Subangil S.H., M.Kn., under the name of PT RNR Film Internasional. The Company started its commercial operations in 2018. The Company does not have a parent entity, the ultimate controlling party is Raffi Farid Ahmad as the Companys shareholder.
Read more on RANS →